Alex A. Adjei
- Molecular Biology top 0.2%
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.1%
- Cancer Research top 0.1%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Julian R. MolinaSteven E. SchildPing YangStephen D. CassiviGrace K. DyIrene M. GhobrialT. E. WitzigYujie Zhao
- Topics
- Lung Cancer Treatments and Mutations (159 papers)Lung Cancer Research Studies (80 papers)Colorectal Cancer Treatments and Studies (59 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Alex A. Adjei
461 papers receiving 25.6k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Biology 12.9k
- Oncology 11.5k
- Pulmonary and Respiratory Medicine 8.2k
- Cancer Research 4.4k
- Pathology and Forensic Medicine 2.5k
Countries citing papers authored by Alex A. Adjei
This map shows the geographic impact of Alex A. Adjei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex A. Adjei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex A. Adjei more than expected).
Fields of papers citing papers by Alex A. Adjei
This network shows the impact of papers produced by Alex A. Adjei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex A. Adjei. The network helps show where Alex A. Adjei may publish in the future.
Co-authorship network of co-authors of Alex A. Adjei
This figure shows the co-authorship network connecting the top 25 collaborators of Alex A. Adjei. A scholar is included among the top collaborators of Alex A. Adjei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex A. Adjei. Alex A. Adjei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 29 | |
| 7 | 16 | |
| 8 | 101 | |
| 9 | Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factorbreakdown → | 438 |
| 10 | 46 | |
| 11 | 42 | |
| 12 | 22 | |
| 13 | 74 | |
| 14 | 41 | |
| 15 | 30 | |
| 16 | 109 | |
| 17 | 100 | |
| 18 | 155 | |
| 19 | Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. | 87 |
| 20 | Comparison of potential markers of farnesyltransferase inhibition. | 103 |
About Alex A. Adjei
Alex A. Adjei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 476 papers that have together received 26.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (159 papers), Lung Cancer Research Studies (80 papers) and Colorectal Cancer Treatments and Studies (59 papers). The work is most often cited by research in Oncology (11.5k citations), Cancer Research (4.4k citations) and Pulmonary and Respiratory Medicine (8.2k citations). Alex A. Adjei has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Julian R. Molina, Steven E. Schild, Ping Yang, Stephen D. Cassivi, Grace K. Dy, Irene M. Ghobrial, T. E. Witzig, Yujie Zhao, Solange Peters and Ronald S. Go. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.